Myocarditis complicating Plasmodium vivax malaria. by Nasir, Noreen et al.
eCommons@AKU
Department of Medicine Department of Medicine
May 2014
Myocarditis complicating Plasmodium vivax
malaria.
Noreen Nasir
Aga Khan University, noreen.nasir@aku.edu
Saima Lalani
Aga Khan University
Zahra Aziz Samani
Aga Khan University
Aysha Almas
aysha.almas@aku.edu
Follow this and additional works at: http://ecommons.aku.edu/pakistan_fhs_mc_med_med
Part of the Infectious Disease Commons, and the Pulmonology Commons
Recommended Citation
Nasir, N., Lalani, S., Samani, Z. A., Almas, A. (2014). Myocarditis complicating Plasmodium vivax malaria.. JCPSP: Journal of the
College of Physicians and Surgeons--Pakistan, 24, s96-s98.
Available at: http://ecommons.aku.edu/pakistan_fhs_mc_med_med/202
S96 Journal of the College of Physicians and Surgeons Pakistan 2014, Vol. 24 (Special Supplement 2): S96-S98
INTRODUCTION
Malaria continues to be a major public health problem in
the tropical developing world. According to the World
Health Organization, in 2010, there were an estimated
216 million cases of malaria in 106 endemic countries
and territories and an estimated 655,000 deaths
because of the disease worldwide. It is endemic
throughout South and South-East Asia, South America
and Africa. Furthermore, approximately half the
world's population is at risk of developing malaria
particularly those that reside in low to middle income
countries.1
Plasmodium (P.) vivax is the most widespread of the four
Plasmodium species (P. falciparum, P. vivax, P. malariae
and P. ovale) that infect human with up to 2·5 billion
people at risk and an estimated 80 million to 300 million
clinical cases every year.2 It is manifested by sudden
onset of fever with chills, headaches and vomiting but
the illness is self-limiting in most cases. Also known as
benign tertian malaria, it is not always benign by
course.3 Serious life threatening complications have
been reported from endemic regions. On the other hand,
Plasmodium falciparum is well-known to be significantly
associated with severe clinical course and complications
such as cerebral malaria, multiorgan failure, shock and
fatal outcome.4
Cardiac complications have rarely been reported in
patients affected by this type of infection. We report here
a case of Plasmodium vivax malaria with an unusual
complication of myocarditis and cardiogenic shock.
CASE REPORT
A 20 years old girl with no prior co-morbids presented to
emergency room (ER) with complains of fever for 8
days, lower abdominal pain and nausea and vomiting for
2 days. The fever was high grade without chills, rigors,
or cough associated with it. The abdominal pain was
dull, constant and non-radiating in character. On
examination, she appeared toxic and dehydrated with
collapsed neck veins. Initial vital signs included a heart
rate of 107 beats/minute, blood pressure of 82/59 mm
Hg and afebrile at that time. Systemic examination
revealed generalized tenderness of the upper abdomen
with no apparent visceromegaly and positive gut
sounds, with coarse crackles and decreased breath
sounds at the right base of lung. Rest of the examination
was unremarkable.
The results of the initial investigations revealed
hemoglobin level of 12.3 g/dl, hematocrit of 36, white cell
count of 10,200/ul and platelets of 25,000/cubic
millimeter. Her peripheral film showed trophozoites and
gametocytes of Plasmodium vivax malaria. Her blood
urea nitrogen was 29 mg/dl, serum creatinine was 0.9
mg/dl; serum concentration of sodium was 132 meq/l, of
potassium was 3.3 meq/l, of chloride was 105 meq/l and
of bicarbonate was 23.2 meq/l. Her coagulation profile
showed prothrombin time of 11 seconds, activated
partial thrombin time of 30.4 seconds. Her blood cultures
reported no growth whereas her immunohistochemistry
for Plasmodium vivax was positive. A chest radiograph
showed infiltrates in the right lower zone. Hence, she
was diagnosed as a case of P. vivax malaria with right
lower lobe pneumonia and hypovolemic shock. She was
treated with Chloroquine phosphate, Levofloxacin 750
mg intravenous (IV) daily and resuscitated with
intravenous (IV) fluids and admitted in the main medical
ward.
In the ward, she became tachypneic with a respiratory
rate of 40 breaths per minute. Her oxygen saturation
dropped to 90% on room air and on examination, she
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was noted to have jugular venous distention and
bilateral fine inspiratory crackles. Her electrocardiogram
showed sinus tachycardia with a heart rate of 140 beats
per minute. Arterial blood gas showed respiratory
alkalosis. At this point, it was thought that she had
developed complicated malaria with pneumonia with
possible acute respiratory distress syndrome (ARDS).
Her medications were modified and she was switched
to Piperacillin/Tazobactam 4.5 g IV TID, Quinine
dihydrochloride 20 mg/kg IV stat followed by 10 mg/kg
IV TID and she was transferred to the intensive care unit.
Subsequently, she developed hypoxemic respiratory
failure necessitating intubation and mechanical
ventilation. She required high ventilator support and a
positive end expiratory pressure (PEEP) of 25 cm H2O.
Vasopressors were started for shock. Her central
venous pressure (CVP) at this time was persistently
more than 16 mmH2O, leading to a suspicion of
pulmonary edema due to a cardiac cause. A
2-dimensional transthoracic echocardiogram was
performed at this point which revealed an ejection
fraction of 30% with severe global hypokinesia. Cardiac
chambers, however, were normal in size and mild to
moderate mitral regurgitation as shown in Figures 1
and 2. The high CVP and low ejection fraction ruled out
the development of ARDS. Hence, this patient had
developed myocarditis secondary to P. vivax malaria.
Her IV fluids were stopped and she was started on
inotropes, dopamine, dobutamine and diuresed with
furosemide. Her repeat CXR confirmed parenchymal
fluid in lungs and bilateral pleural effusions. Blood
picture also revealed a platelet count of 55 and positive
malarial parasite on peripheral film with scanty gameto-
cytes of Plasmodium vivax of 1-10/100 power field. 
Over the next 48 hours, the patient's ventilatory
requirements gradually improved. Repeat complete
blood count (CBC) showed negative malarial parasite on
peripheral film. On 8th day a repeat echocardiogram
revealed normal left ventricular systolic function and
ejection fraction of 60%. The patient was extubated on
the 10th day of admission. Her CBC significantly had
improved with platelets of 558,000, hemoglobin of 10.9
g/dl and a negative peripheral smear for malarial
parasite. Subsequently, the patient was shifted out of
ICU to medical ward again and sent home.
DISCUSSION
We report a case of P. vivax malaria complicated by
secondary myocarditis. Plasmodium vivax infection can
rarely cause various complications which include
ARDS/ALI, acute kidney injury, severe anemia and
thrombocytopenia, hemophagocytic syndrome, as well
as cerebral malaria.3,4 Although there are many cases
reporting cardiac complications associated with
Plasmodium falciparum infection, they have rarely been
reported to be caused by P. vivax infection.
There are four case reports in literature about
Plasmodium vivax infection complicated by myocarditis.
Two of these have been described in children with only
one case reported in an adult patient. The first case was
reported by Herrera et al. about an 8 years old boy who
died due to fatal myocarditis following Plasmodium vivax
malaria.5 The second case was reported by Kim et al.
which links P. vivax infection with myocarditis.6 The
patient presented with fever and chills after travel to an
endemic region in South Korea and was diagnosed with
P. vivax malaria. Subsequently, she developed chest
pain and non-specific ST-T wave changes in lead II, III
and AVF on ECG and was found to have elevated
troponin levels. Her ejection fraction was 61% with
suspicious hypokinetic motion on inferior cardiac wall
and normal global left ventricular systolic function. She
was conservatively managed and her chest pain
resolved followed by cardiac markers which returned to
baseline over a few days. ECG in this patient showed
sinus tachycardia and ST-T flattening in anterior leads
and she developed cardiogenic shock due to severe
myocarditis. A 2-dimensional echocardiogram showed
severely reduced left ventricular systolic function, an
ejection fraction of 30% and global hypokinesia. She
subsequently required assisted ventilation and invasive
hemodynamic monitoring. Hence, this is the first case to
report development of cardiogenic shock secondary to
myocarditis in a patient with P. vivax malaria. In a third
reported case, Plasmodium vivax malaria presented
with an unexpected combination of cerebral malaria
complicated by myocarditis in a 12 years old child.7 A
fourth case report from Northern India is about an
adolescent girl who presented with fever, jaundice and
right upper quadrant abdominal pain. Her clinical course,
similar to our patient was complicated with the
development of respiratory distress secondary to
pulmonary edema, culminating in mechanical venti-
lation. An echocardiogram subsequently revealed
generalized hypokinesia and an ejection fraction of
40%.8
Myocarditis complicating P. vivax malaria is extremely
rare. The exact incidence and pathophysiology of this
entity remains obscure. In Plasmodium falciparum
associated myocarditis, the mechanism of myocardial
injury is a result of a number of parasitic toxins released
in the course of infection that activate the immune
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Figure 1: Echocardiogram. Figure 2: Echocardiogram.
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response.9 Inflammatory cytokines like TNFα are known
to exert toxic effects on the heart causing myocardial
injury. Another mechanism of cardiac injury in malaria is
occlusion of capillaries by parasites and parasitized
RBCs causing ischemic cardiomyopathy.10 Also severe
metabolic acidosis and hypoglycemia can compromise
myocardial integrity and function with high concen-
trations of circulating cardiac biomarkers.
Acute myocarditis has a variable clinical course, ranging
from asymptomatic disease to congestive heart failure
and sudden death. Early recognition of this complication
is important as it may lead to cardiogenic shock which
carries a high mortality. These patients require intensive
care with invasive hemodynamic monitoring and inotro-
pic support. Despite global efforts aimed at eradication
and control of malaria, this disease remains one of the
most important public health challenges of these time.
REFERENCES
1. World Health Organization. World malaria report. Geneva:
WHO Press; 2011. 
2. Guerra CA, Snow RW, Hay SL. Mapping the global extent of
malaria in 2005. Trends Parasitol 2006; 22:353-8.
3. Picot S. Is Plasmodium vivax still a paradigm for uncomplicated
malaria? Med Mal Infect 2006; 36:406-13.
4. Aggarwal A, Rath S, Shashiraj. Plasmodium vivax malaria
presenting with severe thrombocytopenia. J Trop Pediatr 2005;
51:120-2.
5. Herrera JM. [Cardiac lesions in P. vivax malaria. Study of a
case with coronary and myocardial damage]. Arch Inst Cardiol
Mex 1960; 30:26-36. Spanish.
6. Kim SA, Kim ES, Rhee MY, Choi SI, Huh HJ, Chae SL, et al.
A case of myocarditis associated with Plasmodium vivax
malaria. J Travel Med 2009; 16:138-40.
7. Mustafa SA, Patra V, Ali SS. Plasmodium vivax myocarditis in
a child. Int Multidiscipl Res J 2011; 204:45-6.
8. Ahmad S, Dhar M, Bishnoi S, Shirazi N, Bhat NK. Acute
myocarditis in P. vivax malaria: an extremely rare complication.
Trop Doct 2013; 43:35-6. 
9. Kern P, Hemmer CJ, Van Damme J. Elevated tumour necrosis
factor alpha and interleukin-6 serum levels as markers for
complicated Plasmodium falciparum malaria. Am J Med 1989;
87:139.
10. Costenaro P1, Benedetti P, Facchin C, Mengoli C, Pellizzer G.
Fatal myocarditis in course of Plasmodium falciparum
infection: case report and review of cardiac complications in
malaria. Case Rep Med 2011. 
